Skip to contentHome page Seeking Alpha - Power to InvestorsTranscriptsNov. 11, 2025 2:21 PM ETClover Health Investments, Corp. (CLOV) StockCLOVSA Transcripts156.72K FollowersCommentsQ3: 2025-11-04 Earnings SummaryInsightsTranscript InsightsTranscriptEPS of $0.00 misses by $0.02 | Revenue of $496.65M (50.05% Y/Y) beats by $25.57MClover Health Investments, Corp. (CLOV) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM ESTCompany ParticipantsPeter Kuipers - Chief Financial OfficerPresentationUnknown AnalystOkay. All right. Thanks for joining us here today. With us today, we have Clover Health. On stage is CFO, Peter Kuipers. I believe he's going to start off with the presentation.Peter KuipersChief Financial OfficerThank you, Jonathan. Great to be here. Thanks for having us. At Clover Health, our vision is to empower every position with advanced technology to earlier identify, manage and treat chronic diseases and drive better health outcomes and also lower total cost of care. And how are we doing that? We are led by technology, and we're proving the technology out in Medicare Advantage. We are a Medicare Advantage insurance plan led by technology.We have developed over 7, 8 years, large machine learning models and now also powered by AI over the last couple of years., ,technology that can be used by physicians and is increasingly used by physicians to earlier identify, treat and manage chronic diseases.Medicare Advantage is a large market. It's growing 35 million seniors in the U.S. are in that market. We operate our main insurance plan in an open network or a PPO network, mostly focused in our priority markets in New Jersey and Georgia. We are expecting to grow at a similar rate as the last AEP this year.Then also, in addition, we are now bringing this technology also to market for third-party payers and risk-bearing providers. On the payer side, this includes national payers that are in the pipeline and also regional payers. For this year, our current outlook is that we're growing over 30%, 33% growth from membership while maintaining profitability from an EBITDA perspective.Read more current CLOV analysis and newsView all earnings call transcriptsCommentsRecommended For YouSeeking Alpha - Power to InvestorsPower to InvestorsFollow usDownload appContact usSubscription Support: subscriptions@seekingalpha.com© 2025 Seeking AlphaTo ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.Is this happening to you frequently? Please report it on our feedback forum.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.